GlassScriptPhysician profile
Vadim Vaisman
NPI 1588816276
$2,070.57
in general payments reported to CMS, 2019-2025
10 companies · $357 in 2025
The $357 reported for 2025 was more than what 88% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $336 · 2021: $141 · 2022: $449 · 2023: $280 · 2024: $508 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,144.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $758.02 | 2023-2025 | Eluvia, Seismiq Lithotrip_pi, Ranger |
| Allergan, INC. | $546.48 | 2019-2022 | |
| Chiesi USA, INC. | $402.69 | 2019-2024 | Cleviprex |
| Merz North America, INC. | $101.67 | 2024 | |
| Abbvie INC. | $88.13 | 2025 | |
| W. L. Gore & Associates, INC. | $85.45 | 2022 | |
| Potrero Medical, INC. | $34.48 | 2023 | |
| Reflow Medical INC | $23.00 | 2025 | |
| Terumo Medical Corporation | $17.03 | 2022 | |
| Medtronic, INC. | $13.62 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vadim Vaisman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.